Revolutionising Cancer Treatment with AI & Nanotechnology
At Prosemble, we are transforming cancer care with cutting-edge nanoparticle and AI technologies enhancing treatment efficacy while minimising side effects.
Cancer Cases every year
Chemotherapy Patients
Oncology market size in 2030
Pioneering Advancements
Our protein-based nanoparticle delivery system permits disease-specific targeting mechanisms, versatile drug loading for therapeutics, and atomic-level structural precision, offering enhanced engineering for superior cancer treatment.
Side effects experienced by patients...
%
Fatigue
%
Peripheral Neuropathy
%
Hair Loss
%
Liver Damage
%
Mucositis
%
Kidney Damage
%
of patients going through chemo experience significant side effects
%
fewer drugs required with Prosemble technology
%
of medicine currently gets to the tumours
Through Our Science We Are Transforming Cancer Treatment for Chemotherapy Patients
Latest News
Prosemble Awarded Innovate UK Biomedical Catalyst Grant
Prosemble has been awarded funding through the Innovate UK Biomedical Catalyst (BMC) Femtech & AI in Health: Feasibility Competition 2025. The grant will support research into targeted drug delivery for EGFR-positive lung cancer using protein nanoparticles and...
Inna Zhuranskaya Attends Supercharging Innovation in AI, Data Science, and Health Care
Inna Zhuranskaya attended Supercharging Innovation in AI, Data Science, and Health Care, which brought together leaders from government, academia, and industry to explore how the UK can accelerate innovation in health care. The event featured welcome remarks from...
Inna Zhuranskaya Attends TCS Good Growth Event in Collaboration with Exponent Women
On 10 October, Inna Zhuranskaya attended the TCS Good Growth Event in collaboration with Exponent Women. This year marks the fifth anniversary of the event — a milestone celebration bringing together leaders, investors, and innovators to discuss growth, technology,...